Sodium triphosphate–capped silver nanoparticles on a decellularized scaffold-based polyurethane vascular patch for bacterial infection inhibition and rapid endothelialization
Restricted accessResearch articleFirst published online July, 2019
Sodium triphosphate–capped silver nanoparticles on a decellularized scaffold-based polyurethane vascular patch for bacterial infection inhibition and rapid endothelialization
With increasing incidence rate of cardiovascular diseases and implant-related infections, there is growing demand for vascular patches that can promote endothelialization and resist bacterial infection. In this work, we immobilized sodium triphosphate–capped silver nanoparticles onto a polyurethane film to obtain a composite film and evaluated its in vitro biocompatibility. Subsequently, we anchored sodium triphosphate–capped silver nanoparticles onto a polyurethane-coated decellularized scaffold to prepare a vascular patch and investigated its in vivo performance in a mouse model. The prepared vascular patch demonstrated excellent biocompatibility and potent antibacterial activity against Escherichia coli and Staphylococcus aureus. It still maintained the surgical artery patency at 30 days after implantation. At the same time, the endothelialization at the surgical site was achieved, showing its ability to facilitate endothelialization. Therefore, it may be a promising candidate for combating bacterial infection and treating diseased blood vessels.
AsadpourSYeganehHAiJ, et al. A novel polyurethane modified with biomacromolecules for small-diameter vascular graft applications. J Mater Sci2018; 53(14): 9913–9927.
2.
ZhuHMFuLHeL, et al. Polyurethane–cardiolipin nanoparticle-modified decellularized scaffold-based vascular patches for tissue engineering applications. ACS Appl Bio Mater2019; 2(4): 1696–1702.
3.
ZhangJWangDWJiangXF, et al. Multistructured vascular patches constructed via layer-by-layer self-assembly of heparin and chitosan for vascular tissue engineering applications. Chem Eng J2019; 370: 1057–1067.
4.
ZhangJFengFWangDW, et al. A vascular patch fabricated by cosedimentating polyurethane and polymeric nanoparticles onto a decellularized scaffold facilitates endothelialization. J Biomater Tiss Eng2018; 8(7): 979–988.
5.
LeeHYangJHJunTG, et al. Augmentation of the lesser curvature with an autologous vascular patch in complex aortic coarctation and interruption. An Thorac Surg2016; 101(6): 2309–2314.
6.
TuQFZhangYGeDX, et al. Novel tissue-engineered vascular patches based on decellularized canine aortas and their recellularization in vitro. Appl Surf Sci2008; 255(2): 282–285.
7.
OtsukaFFinnAVYazdaniSK, et al. The importance of the endothelium in atherothrombosis and coronary stenting. Nat Rev Cardiol2012; 9(8): 439–453.
8.
ZhangJLiuCFengFL, et al. A PC-PU nanoparticle/PU/decellularized scaffold composite vascular patch: synergistically optimized overall performance promotes endothelialization. Colloids Surf B Biointerfaces2017; 160(1): 192–200.
9.
BaiLCZhaoJLiQ, et al. Biofunctionalized electrospun PCL-PIBMD/SF vascular grafts with PEG and cell-adhesive peptides for endothelialization. Macromol Biosci2019; 19(2): e1800386.
10.
ChoiDHKangSNKimSN, et al. Growth factors-loaded stents modified with hyaluronic acid and heparin for induction of rapid and tight re-endothelialization. Colloids Surf B Biointerfaces2016; 141: 602–610.
11.
ZhangJWangYTLiuC, et al. Polyurethane/polyurethane nanoparticle-modified expanded poly(tetrafluoroethylene) vascular patches promote endothelialization. J Biomed Mater Res A2018; 106(8): 2131–2140.
12.
StaneviciuteENa’amnihWKavaliauskasP, et al. New in vitro model evaluating antiseptics’ efficacy in biofilm-associated Staphylococcus aureus prosthetic vascular graft infection. J Med Microbiol2019; 68(3): 432–439.
13.
Hernández-RichterTSchardeyHMWittmannF, et al. Rifampin and triclosan but not silver is effective in preventing bacterial infection of vascular Dacron graft material. Eur J Vasc Endovasc Surg2003; 26(5): 550–557.
14.
TammerIReunerJHartigR, et al. Induction of Candida albicans biofilm formation on silver-coated vascular grafts. J Antimicrob Chemother2014; 69(5): 1282–1285.
15.
LuoJPorteousNLinJJ, et al. Acyclic N-halamine-immobilized polyurethane: preparation and antimicrobial and biofilm-controlling functions. J Bioact Compat Polym2015; 30(2): 157–166.
16.
KaraFAksoyEACalamakS, et al. Immobilization of heparin on chitosan-grafted polyurethane films to enhance anti-adhesive and antibacterial properties. J Bioact Compat Polym2016; 31(1): 72–90.
17.
LiYYDongYJYangY, et al. Rational design of silver gradient for studying size effect of silver nanoparticles on contact killing. ACS Biomater Sci Eng2019; 5(2): 425–431.
18.
XuTZhangJMZhuYN, et al. A poly (hydroxyethyl methacrylate)–Ag nanoparticle porous hydrogel for simultaneous in vivo prevention of the foreign-body reaction and bacterial infection. Nanotechnology2018; 29(39): 395101.
19.
ArciolaCRCampocciaDSpezialeP, et al. Biofilm formation in staphylococcus implant infections. A review of molecular mechanisms and implications for biofilm-resistant materials. Biomaterials2012; 33(26): 5967–5982.
20.
HoqueJAkkapeddiPGhoshC, et al. A biodegradable polycationic paint that kills bacteria in vitro and in vivo. ACS Appl Mater Interfaces2016; 8(43): 29298–29309.
21.
BusscherHJAltVvan der MeiHC, et al. A trans-Atlantic perspective on stagnation in clinical translation of antimicrobial strategies for the control of biomaterial-implant-associated infection. ACS Biomater Sci Eng2019; 5(2): 402–406.
22.
NagpalASohailMR. Prosthetic vascular graft infections: a contemporary approach to diagnosis and management. Curr Infect Dis Rep2011; 13(4): 317–323.
MestresCAQuintanaEKopjarT, et al. Twenty-year experience with cryopreserved arterial allografts for vascular infections. Eur J Cardiothorac Surg2018; 55(2): 358–365.
25.
RiccoJBAssadianO. Antimicrobial silver grafts for prevention and treatment of vascular graft infection. Semin Vasc Surg2011; 24(4): 234–241.
26.
AnYHFriedmanRJ. Handbook of bacterial adhesion: principles, methods, and applications. 1st ed. Totowa, NJ: Humana Press, 2000, pp. 73–90.
27.
TaheriSCavallaroAChristoSN, et al. Antibacterial plasma polymer films conjugated with phospholipid encapsulated silver nanoparticles. ACS Biomater Sci Eng2015; 1(12): 1278–1286.
28.
PoelstraKABarekziNARediskeAM, et al. Prophylactic treatment of gram-positive and gram-negative abdominal implant infections using locally delivered polyclonal antibodies. J Biomed Mater Res2002; 60(1): 206–215.
29.
TangLZZhuLTangF, et al. Mild synthesis of copper nanoparticles with enhanced oxidative stability and their application in antibacterial films. Langmuir2018; 34(48): 14570–14576.
30.
Adebayo-TayoBCInemSAOlaniyiOA. Rapid synthesis and characterization of gold and silver nanoparticles using exopolysaccharides and metabolites of wesiella confusa as an antibacterial agent against Escherichia coli. Int J Nano Dimens2019; 10(1): 37–47.
31.
KalishwaralalKBarathManiKanthSPandianSRK, et al. Silver nanoparticles impede the biofilm formation by Pseudomonas aeruginosa and Staphylococcus epidermidis. Colloids Surf B Biointerfaces2010; 79(2): 340–344.
32.
DeshmukhSPPatilSMMullaniSB, et al. Silver nanoparticles as an effective disinfectant: a review. Mater Sci Eng C Mater Biol Appl2019; 97: 954–965.
33.
GeLPLiQTWangM, et al. Nanosilver particles in medical applications: synthesis, performance, and toxicity. Int J Nanomed2014; 9: 2399–2407.
McShanDRayPCYuHT. Molecular toxicity mechanism of nanosilver. J Food Drug Anal2014; 22(1): 116–127.
36.
AshaRaniPVMunGLKHandeMP, et al. Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano2009; 3(2): 279–290.
37.
AhamedMAlSalhiMSSiddiquiMKJ. Silver nanoparticle applications and human health. Clin Chim Acta2010; 411(23−24): 1841–1848.
38.
GreulichCBraunDPeetschA, et al. The toxic effect of silver ions and silver nanoparticles towards bacteria and human cells occurs in the same concentration range. RSC Adv2012; 2(17): 6981–6987.
39.
LiuLHYangJXieJP, et al. The potent antimicrobial properties of cell penetrating peptide-conjugated silver nanoparticles with excellent selectivity for gram-positive bacteria over erythrocytes. Nanoscale2013; 5(9): 3834–3840.
40.
GuoQQZhaoYDaiXM, et al. Functional silver nanocomposites as broad-spectrum antimicrobial and biofilm-disrupting agents. ACS Appl Mater Interfaces2017; 9(20): 16835–16848.
41.
HoqueJYadavVPrakashRG, et al. Dual-function polymer–silver nanocomposites for rapid killing of microbes and inhibiting biofilms. ACS Biomater Sci Eng2019; 5(1): 81–91.
42.
ChengCHLiuCHanB, et al. Silver nanoparticles modified with sodium triphosphate: antibacterial activity, hemocompatibility and cytotoxicity. J Nanosci Nanotechnol2018; 18(6): 3816–3824.
43.
KangKLimDHChoiIH, et al. Vascular tube formation and angiogenesis induced by polyvinylpyrrolidone-coated silver nanoparticles. Toxicol Lett2011; 205(3): 227–234.
44.
ZhangJSunZJZhuHM, et al. Novel triphosphorylation polyurethane nanoparticles for blood-contacting biomaterials’ coating. J Mater Chem B2016; 4(6): 1116–1121.
45.
SalaheldinHIAlmalkiMHKHezmaAM, et al. Facile synthesis of silver nanoparticles mediated by polyacrylamide-reduction approach to antibacterial application. IET Nanobiotechnol2016; 11(4): 448–453.
46.
YuMMDingXJZhuYW, et al. Facile surface multi-functionalization of biomedical catheters with dual-microcrystalline broad-spectrum antibacterial drugs and antifouling poly(ethylene glycol) for effective inhibition of bacterial infections. ACS Appl Bio Mater2019; 2(3): 1348–1356.
47.
HanCJYaoYChengX, et al. Electrophoretic deposition of gentamicin-loaded silk fibroin coatings on 3D-printed porous cobalt–chromium–molybdenum bone substitutes to prevent orthopedic implant infections. Biomacromolecules2017; 18(11): 3776–3787.
48.
TranCDProsencFFrankoM, et al. One-pot synthesis of biocompatible silver nanoparticle composites from cellulose and keratin: characterization and antimicrobial activity. ACS Appl Mater Interfaces2016; 8(50): 34791–34801.
49.
TianYQiJJZhangW, et al. Facile, one-pot synthesis, and antibacterial activity of mesoporous silica nanoparticles decorated with well-dispersed silver nanoparticles. ACS Appl Mater Interfaces2014; 6(15): 12038–12045.
50.
PanacekAKvitekLPrucekR, et al. Silver colloid nanoparticles: synthesis, characterization, and their antibacterial activity. J Phys Chem B2006; 110(3): 16248–16253.
51.
FuJHJiJFanDZ, et al. Construction of antibacterial multilayer films containing nanosilver via layer-by-layer assembly of heparin and chitosan-silver ions complex. J Biomed Mater Res A2006; 79(3): 665–674.
52.
LiliensiekSJWoodJAYongJA, et al. Modulation of human vascular endothelial cell behaviors by nanotopographic cues. Biomaterials2010; 31(20): 5418–5426.
53.
Rosales-LealJIRodriguez-ValverdeMAMazzagliaG, et al. Effect of roughness, wettability and morphology of engineered titanium surfaces on osteoblast-like cell adhesion. Colloids Surf A2010; 365(1−3): 222–229.
54.
ChenLHanDJiangL. On improving blood compatibility: from bioinspired to synthetic design and fabrication of biointerfacial topography at micro/nano scales. Colloids Surf B Biointerfaces2011; 85(1): 1–7.
55.
OstdiekAMIveyJRHansenSA, et al. Feasibility of a nanomaterial-tissue patch for vascular and cardiac reconstruction. J Biomed Mater Res B Appl Biomater2016; 104(3): 449–457.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
